H1 FY27 PAT rises 50.1% as revenue grows 28.7%
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For H1 FY27 ended September 30, 2026, revenue rose 28.7% to Rs 1,269 crore and EBITDA rose 27.0% to Rs 362 crore, with a 28.2% margin. Profit after tax increased 50.1% to Rs 112 crore. Surgeries rose 18.8% to 186,923, while the network reached 324 facilities after 39 additions.
Strong profit growth supports sentiment. Network expansion offers upside, but continued capital and acquisition spending may pressure cash flow.